KFDA to approve an oral quit-smoking remedy, Champix.

The KFDA announced an approval of Champix (varenicline tartrate), an oral quit-smoking remedy as of March 30 filed by Pfizer Korea based on the clinical study evidences of showing 60% success in quitting smoking. Now, Champix may trigger a hot competition on the market.

At present, the quit-smoking market has been dominated by 3 big patch type of products, namely, Nicostop (developed by Sam...